Most current supply chains are entirely inadequate for the realities of trials today. Right Now distribution reduced all categories of waste, when compared to traditional models.Read the Case Study “Right Now Distribution in Clinical Trials”
The clinical trials of today grow increasingly challenging due to complexity of study design and focused target population and clinical indications. A need to aggregate, analyze and leverage ever-increasing volumes of information requires real-time data integration to enable quick evaluation and response for effective Clinical Software conduct including the supply of limited quantities of environmentally-sensitive and costly investigational products. Learn how we address this issue in the White Paper “Application of the Right Now Model – Intelligent Data Platform for On-Demand Dosing and Distribution in Clinical Trials”
Bioavailability and Bioequivalence Studies for Orally Administered Drug Products — General Considerations Learn More
Clinical Pharmacogenomics: Premarket Evaluation in Early-Phase Clinical Studies and Recommendations for Labeling Learn More
Oversight of Clinical Investigations — A Risk-Based Approach to Monitoring Learn More
Reducing Clinical Costs With The Right Drug Distribution Strategy, Clinical Leader
Risk-Based Monitoring: A More Strategic Approach To Site Monitoring And Clinical Data Management, Clinical Leader
